(R)-[(R)-3-Benzyl-2-oxooxazolidin-4-yl]-[4-(methylsulfonyl)phenyl] methyl acetate

被引：0
|
作者：
Li, Feng [1 ]
Zhao, Ming-Zhong [2 ]
Jin, Chun-Hua [1 ]
Zou, Jian-Wei [1 ]
机构：
[1] Zhejiang Univ, Sch Biol & Chem Engn, Ningbo Inst Technol, Ningbo 315100, Zhejiang, Peoples R China
[2] Ningbo Ocean & Fishery Bur, Ningbo 315100, Zhejiang, Peoples R China
来源：
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS | 2014年 / 70卷
关键词：
data-to-parameter ratio = 14.3; mean σ(C-C) = 0.004 A°; R factor = 0.035; single-crystal X-ray study; T = 296 K; wR factor = 0.091;
D O I：
10.1107/S1600536814009106
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
The structure of the title compound, C20H21NO6S, is of interest with respect to its antibacterial properties. The oxazolidine ring makes dihedral angles of 79.63 (14) and 56.16 (12)degrees with the phenyl and benzene rings, respectively, while the phenyl and benzene rings make a dihedral angle of 64.37 (13)degrees. In the crystal, non-classical C-H center dot center dot center dot O hydrogen bonds link adjacent molecules along the c axis.
引用
收藏
页码：O606 / +
页数：9
相关论文
共 50 条
  • [1] Syntheses and pharmacological activities of chiral fomocaines ({4-[2-methyl-3-(morpholin-4-yl)propyl]benzyl}-phenyl-ether and {4-[1-methyl-3-(morpholin-4-yl)propyl]benzyl}-phenyl-ether)
    Oelschläger, H
    Glassl, P
    Seeling, A
    Wange, J
    Listing, M
    Jung, B
    PHARMAZIE, 2001, 56 (08): : 620 - 625
  • [2] 4-chloro-2-{4-[p-(methylsulfonyl)phenyl]-2-oxo-5-phenyl-2,3-dihydro-1,3-oxazol-3-yl}-phenyl acetate
    Tsou, NN
    Ball, RG
    Roy, PJ
    Leblanc, Y
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1998, 54 : 1493 - 1494
  • [3] Discovery of 5-methyl-2-(4-((4-(methylsulfonyl)benzyl)oxy)phenyl)-4-(piperazin-1-yl)pyrimidine derivatives as novel GRP119 agonists for the treatment of diabetes and obesity
    Chen, Jinying
    Sang, Zitai
    Li, Lu
    He, Linhong
    Ma, Liang
    MOLECULAR DIVERSITY, 2017, 21 (03) : 637 - 654
  • [4] Discovery of 5-methyl-2-(4-((4-(methylsulfonyl)benzyl)oxy)phenyl)-4-(piperazin-1-yl)pyrimidine derivatives as novel GRP119 agonists for the treatment of diabetes and obesity
    Jinying Chen
    Zitai Sang
    Lu Li
    Linhong He
    Liang Ma
    Molecular Diversity, 2017, 21 : 637 - 654
  • [5] 4-(7-acetoxy-6-methoxy-4-methyl-2-oxo-2H-chromen-3-yl)phenyl acetate
    Jiang, Hao
    Xia, Peng
    Zhang, Qian
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O1230 - U1578
  • [6] 2-[4-(Methylsulfonyl)phenyl]acetonitrile
    Fun, Hoong-Kun
    Quah, Ching Kheng
    Sumangala, V.
    Prasad, D. Jagadeesh
    Poojary, Boja
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O574 - U1324
  • [7] N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide
    Korlyukov, Alexander A.
    Dorovatovskii, Pavel V.
    Vologzhanina, Anna V.
    MOLBANK, 2022, 2022 (04)
  • [8] Synthesis of aryl {4-[({5-[3-(methylsulfonyl)phenyl]pyrazin-2-yl}-oxy)methyl]piperidin-1-yl}methanones
    Sriramudu, B.
    Satyanarayana, B.
    Muralikrishna, P.
    Ramachandran, D.
    Journal of Chemical and Pharmaceutical Research, 2014, 6 (07) : 1873 - 1883
  • [9] (3R,4S)-3-Phenyl-1-[(R)-1-phenyl-ethyl]-4-[(R)-1-phenylethylimino-methyl]azetidin-2-one
    Kooijman, Huub (h.kooijman@chem.uu.nl), 2000, International Union of Crystallography, 5 Abbey Road, Chester, CH1 2HU, United Kingdom (56)
  • [10] (±)-(4-Oxo-4H-chromen-2-yl)-(phenyl)methyl acetate
    Malecka, M
    Massa, W
    Budzisz, E
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2004, 60 : O762 - O764
12345